Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients
- PMID: 35603235
- PMCID: PMC9104676
- DOI: 10.15167/2421-4248/jpmh2021.62.4.2254
Epidemiological characteristics and outcomes of COVID-19 in asymptomatic versus symptomatic patients
Abstract
Background: The clinical manifestations of COVID-19 are different, which can be attributed to asymptomatic carriers, acute respiratory disease and pneumonia with different severities. The aim of this study was to compare the epidemiological characteristics and outcomes of COVID-19 in patients with clinical symptoms versus asymptomatic patients.
Methods: In this retrospective cohort study, the epidemiological characteristics of two groups of patients, with clinical symptoms (n = 38,630) and without clinical symptoms who were definitive cases of COVID-19 (n = 2,327) were investigated in the southwestern of Iran. Chi-square test was used to evaluate the differences between qualitative variables in the two study groups.
Results: Of 40,957 patients with COVID-19, 2,327 (5.68%) were asymptomatic, of whom 1391 (59.77%) were males, 1841 patients (79.11%) had a history of contact with definite or suspected cases of COVID-19. Asymptomatic patients were older than symptomatic cases. Patients with clinical symptoms had higher mortality rate than asymptomatic patients (2.68% in symptomatic patients vs 0% in asymptomatic patients).
Conclusion: According to the results of our study, the detected viral load in asymptomatic individuals was similar to that of symptomatic patients, indicating that asymptomatic infections can potentially transmit the disease. Therefore, screening and detection of asymptomatic cases is an important and key measure in prevention and early control of COVID-19 worldwide.
Keywords: Asymptomatic infection; COVID-19; Patients with clinical symptoms.
©2021 Pacini Editore SRL, Pisa, Italy.
Conflict of interest statement
Conflict of interest statement The authors declare no conflict of interest.
Similar articles
-
Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.Virol J. 2021 Jun 12;18(1):126. doi: 10.1186/s12985-021-01597-x. Virol J. 2021. PMID: 34118952 Free PMC article.
-
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.JAMA Intern Med. 2020 Nov 1;180(11):1447-1452. doi: 10.1001/jamainternmed.2020.3862. JAMA Intern Med. 2020. PMID: 32780793 Free PMC article.
-
Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.J Korean Med Sci. 2020 Sep 21;35(37):e333. doi: 10.3346/jkms.2020.35.e333. J Korean Med Sci. 2020. PMID: 32959547 Free PMC article.
-
Epidemiological, Radiographical, and Laboratorial Characteristics of Chinese Asymptomatic Cases With COVID-19: A Systematic Review and Meta-Analysis.Front Public Health. 2022 Mar 31;10:808471. doi: 10.3389/fpubh.2022.808471. eCollection 2022. Front Public Health. 2022. PMID: 35433622 Free PMC article.
-
A systematic review of asymptomatic infections with COVID-19.J Microbiol Immunol Infect. 2021 Feb;54(1):12-16. doi: 10.1016/j.jmii.2020.05.001. Epub 2020 May 15. J Microbiol Immunol Infect. 2021. PMID: 32425996 Free PMC article.
Cited by
-
Perioperative outcomes in patients with symptomatic versus asymptomatic previous COVID-19 infection undergoing neurosurgical treatment (post-COVID-19 study).J Anaesthesiol Clin Pharmacol. 2025 Jan-Mar;41(1):98-105. doi: 10.4103/joacp.joacp_313_23. Epub 2024 Dec 16. J Anaesthesiol Clin Pharmacol. 2025. PMID: 40026747 Free PMC article.
-
Severe acute respiratory syndrome coronavirus 2 seroprevalence among patients with pulmonary tuberculosis.Rev Assoc Med Bras (1992). 2023 Sep 18;69(9):e20230661. doi: 10.1590/1806-9282.20230661. eCollection 2023. Rev Assoc Med Bras (1992). 2023. PMID: 37729381 Free PMC article.
References
-
- Alipour A, Ghadami A, Alipour Z, Abdollahzadeh H. Preliminary Validation of the Corona Disease Anxiety Scale (CDAS) in the Iranian Sample 2020;8:163-75. https://doi.org/10.30473/HPJ.2020.52023.4756 10.30473/HPJ.2020.52023.4756 - DOI
-
- Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y, Sun B, Wei M, Yang G, Wang X, Zhang L, Zhou X, Xing M, Wang PG. Relationship between the ABO Blood Group and the COVID-19 Susceptibility. Clin Infect Dis 2021;73:328-31. https://doi.org/10.1093/cid/ciaa1150 10.1093/cid/ciaa1150 - DOI - PMC - PubMed
-
- Kalteh EA, Sofizadeh A, Fararooei M, Ghojogh MG, Aljalili S. Measures of Mortality in Coronavirus (COVID-19) Compared with SARS and MERS. Journal of Cellular & Molecular Anesthesia. 2020;5:97-101. https://doi.org/10.22037/jcma.v5i2.30220 10.22037/jcma.v5i2.30220 - DOI
-
- Honarvar MR, Roshandel G, Shirzad-Aski H, Tabarraei A, Tahamtan A, Ghelichi-Ghojogh M. Epidemiological and clinical characteristics of the COVID-19 epidemic and associated factors for mortality in Golestan province, Iran: a retrospective cohort study. J Prev Med Hyg 2021;62:E298. https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1910 10.15167/2421-4248/jpmh2021.62.2.1910 - DOI - PMC - PubMed
-
- Azarbakhsh H, Jokari K, Moftakhar L, Ghelichi-Ghojogh M, Karimyan A, Salmanzadeh S. Epidemiological characteristics of patients with COVID-19 in Southwest of Iran from February 19 to June 20, 2020. Med J Islam Repub Iran 2021;35:875-9. doi:10.47176/mjiri.35.116 10.47176/mjiri.35.116 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical